Toth Financial Advisory’s Biogen BIIB Stock Holding History

Toth Financial Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.2K	Buy	76 +66	+660%	+$14K	﹤0.01%	523
2026 Q2	$2.16K	Hold	10	–	–	﹤0.01%	743
2026 Q1	$1.83K	Buy	+10	New	+$1.84K	﹤0.01%	729
2023 Q2	–	Sell	-7	Closed	-$1.95K	–	788
2023 Q1	$1.95K	Buy	+7	New	+$1.94K	﹤0.01%	656
2021 Q4	–	Sell	-36	Closed	-$10K	–	759
2021 Q3	$10K	Buy	+36	New	+$11.8K	﹤0.01%	475
2020 Q4	–	Sell	-8	Closed	-$2K	–	597
2020 Q3	$2K	Hold	8	–	–	﹤0.01%	469
2020 Q2	$2K	Hold	8	–	–	﹤0.01%	458
2020 Q1	$3K	Hold	8	–	–	﹤0.01%	359
2019 Q4	$2K	Buy	+8	New	+$2.22K	﹤0.01%	407
2019 Q1	–	Sell	-10	Closed	-$3K	–	418
2018 Q4	$3K	Hold	10	–	–	﹤0.01%	356
2018 Q3	$4K	Buy	+10	New	+$3.44K	﹤0.01%	368
2018 Q1	–	Sell	-10	Closed	-$3K	–	427
2017 Q4	$3K	Buy	+10	New	+$3.21K	﹤0.01%	377

Other funds holding BIIB

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return

BCM

Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Toth Financial Advisory's BIIB Position: Q3 2026 in Review

Toth Financial Advisory increased its Biogen (BIIB) stake by 660% in Q3 2026, buying an estimated $14K and bringing the position to 76 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Toth Financial Advisory first reported a position in BIIB in Q4 2017 and has held it in 12 quarters since. 31 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Toth Financial Advisory held 76 shares of Biogen worth $17.2K as of Q3 2026.
Toth Financial Advisory bought 66 Biogen shares in Q3 2026, an estimated $14K.
Biogen made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #523 holding.
Toth Financial Advisory first reported a position in Biogen in Q4 2017 and has held it in 12 quarters since.
31 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.